| |
| |
|
| Insider
Information: |
Wheeler Kurt |
| Relationship: |
10% Owner |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
20 |
|
| Direct
Shares |
8,638,466 |
|
|
Indirect Shares
|
50,230,112 |
|
|
| Direct
Value |
$53,697,831 |
|
|
|
Indirect Value
|
$221,892,016 |
|
|
| Total
Shares |
58,868,578 |
|
|
| Total
Value |
$275,589,847 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
6
|
|
Stock
price went up :
|
1
|
6
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
6.0
|
| Percentage
Gain/Loss : |
 12.5%
|
44.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2003-06-26 |
3,612,947 |
2004-09-13 |
475,026 |
Premium* |
|
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2004-03-16 |
87,899 |
Premium* |
|
|
Hemosense Inc |
HEM |
Director, 10% Owner |
2005-07-01 |
0 |
2007-11-06 |
0 |
Premium* |
|
|
American Cryostem Corporation |
CRYO |
Director, 10% Owner |
2005-07-13 |
0 |
2008-05-28 |
0 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director, 10% Owner |
2009-12-31 |
57,377 |
2009-12-31 |
4,632,562 |
Premium* |
|
|
Poniard Pharmaceuticals |
PARD |
10% Owner |
|
0 |
2009-11-09 |
6,363,249 |
Premium* |
|
|
Affymax Inc |
AFFY |
10% Owner |
|
0 |
2006-12-20 |
1,600,469 |
Premium* |
|
|
Helicos Biosciences Corp |
HLCSQ |
10% Owner |
2007-05-30 |
0 |
2007-05-30 |
2,987,769 |
Premium* |
|
|
Ithaka Acquisition Corp |
ITHKU |
Director, 10% Owner |
|
0 |
2007-06-21 |
2,672,568 |
Premium* |
|
|
Aryx Therapeutics Inc |
ARYX |
10% Owner |
2007-11-13 |
0 |
2008-11-14 |
5,364,572 |
Premium* |
|
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
|
0 |
2011-10-27 |
11,133,961 |
Premium* |
|
|
Aveo Pharmaceuticals Inc |
AVEO |
Former 10% Stockholder |
2010-03-17 |
0 |
2010-03-17 |
2,208,961 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
Director, 10% Owner |
2010-11-29 |
0 |
2010-11-29 |
5,982,439 |
Premium* |
|
|
Humanigen Inc |
HGEN |
10% Owner |
2013-02-05 |
0 |
2013-02-05 |
2,632,928 |
Premium* |
|
|
Aerie Pharmaceuticals Inc |
AERI |
10% Owner |
2015-01-28 |
0 |
2013-10-25 |
0 |
Premium* |
|
|
Oxford Immunotec Global Plc |
OXFD |
10% Owner |
2015-06-16 |
2,237,377 |
2013-11-22 |
0 |
Premium* |
|
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
2014-06-06 |
0 |
2016-09-27 |
2,459,804 |
Premium* |
|
|
Iveric Bio Inc |
ISEE |
10% Owner |
2015-05-26 |
0 |
2014-06-11 |
4,500 |
Premium* |
|
|
Sientra, Inc. |
SIEN |
10% Owner |
2014-10-28 |
2,730,765 |
|
0 |
Premium* |
|
|
Entasis Therapeutics Holdings Inc. |
ETTX |
10% Owner |
2018-09-28 |
0 |
2018-09-28 |
1,623,405 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
137 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HEM |
Hemosense Inc |
Director |
– • • |
2007-09-12 |
4 |
S |
$12.75 |
$3,834,093 |
I/I |
(300,600) |
4,003,119 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
– – • |
2004-04-08 |
4 |
S |
$19.93 |
$6,295,927 |
I/I |
(315,902) |
3,834,669 |
|
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
officerTitle |
– • • |
2005-12-20 |
4 |
B |
$11.00 |
$3,498,000 |
I/I |
318,000 |
3,527,874 |
2.25 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2013-10-25 |
4/A |
B |
$10.00 |
$3,210,000 |
D/D |
321,000 |
3,468,494 |
2.45 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
– – • |
2013-10-25 |
4 |
B |
$10.00 |
$3,210,000 |
D/D |
321,000 |
3,653,306 |
2.45 |
- |
|
| HLCSQ |
Helicos Biosciences Corp |
10% Owner |
– – • |
2007-05-30 |
4 |
B |
$9.00 |
$2,999,997 |
I/I |
333,333 |
2,987,769 |
1.5 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
– – • |
2011-10-20 |
4 |
S |
$1.03 |
$437,750 |
I/I |
(425,000) |
12,476,068 |
0 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
10% Owner |
– – • |
2018-09-28 |
4 |
B |
$15.00 |
$6,800,925 |
I/I |
453,395 |
1,623,405 |
1.5 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Former 10% Owner |
– – – |
2004-09-13 |
4 |
A |
$0.00 |
$0 |
I/I |
475,026 |
475,026 |
|
- |
|
| RDUS |
Radius Health Inc. |
10% Owner |
– – • |
2014-06-06 |
4 |
A |
$0.00 |
$0 |
I/I |
694,449 |
3,689,706 |
0 |
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
– – • |
2011-10-27 |
4 |
S |
$1.03 |
$760,971 |
I/I |
(738,807) |
11,133,961 |
0 |
- |
|
| HEM |
Hemosense Inc |
Director |
– • • |
2005-07-01 |
4 |
B |
$5.50 |
$4,214,980 |
I/I |
766,360 |
4,303,719 |
2.25 |
- |
|
| PARD |
Poniard Pharmaceuticals |
10% Owner |
– – • |
2007-04-30 |
4 |
B |
$6.33 |
$5,697,000 |
I/I |
900,000 |
6,858,211 |
1.5 |
- |
|
| ETTX |
Entasis Therapeutics Hold... |
10% Owner |
– – • |
2018-09-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,097,753 |
1,170,010 |
0 |
- |
|
| RDUS |
Radius Health Inc. |
Former 10% stockholder |
– – – |
2016-09-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,229,902) |
2,459,804 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
Director |
– • • |
2009-07-08 |
4 |
B |
$1.05 |
$1,340,423 |
I/I |
1,276,593 |
4,632,562 |
2.25 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
– – • |
2004-06-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,499,989) |
1,833,597 |
|
- |
|
| AFFY |
Affymax Inc |
10% Owner |
– – • |
2006-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,534,898 |
1,600,469 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
10% Owner |
– – • |
2015-05-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,554,744) |
0 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Former 10% Owner |
– – – |
2004-09-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,687,072) |
0 |
|
- |
|
| ZGNX |
Zogenix, Inc. |
Director |
– • • |
2010-11-29 |
4 |
B |
$4.00 |
$7,000,000 |
I/I |
1,750,000 |
5,982,439 |
2.25 |
- |
|
| ARYX |
Aryx Therapeutics Inc |
10% Owner |
– – • |
2008-11-14 |
4 |
B |
$2.20 |
$3,932,962 |
I/I |
1,787,710 |
5,364,572 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Former 10% Stockholder |
– – – |
2010-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
2,208,961 |
2,208,961 |
0 |
- |
|
| OXFD |
Oxford Immunotec Global P... |
10% Owner |
– – • |
2013-11-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,579,062 |
2,579,062 |
0 |
- |
|
| HGEN |
Humanigen Inc |
10% Owner |
– – • |
2013-02-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,632,928 |
2,632,928 |
0 |
- |
|
137 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
